跳至主要内容
临床试验/NCT03619694
NCT03619694Unknown不适用

Role of Magnetic Resonance Spectroscopy in Differentiating Brain Tumors

Assiut University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Comparison of MRS findings with the pathology of the specimens

研究概览

简要总结

In order to come as close as possible to the correct diagnosis of CNS tumors, MRI is the long-standing accepted method of choice that can in some cases be supported by the use of CT to demonstrate calcification or bone destruction. In individual cases MRI spectroscopy can be helpful for the differentiation between neoplasms and inflammatory lesions or surveillance of tumor therapy, just as perfusion

详细描述

Proton magnetic resonance spectroscopy (H-MRS) may be helpful in suggesting tumor histology and tumor grade and may better define tumor extension and the ideal site for biopsy compared with conventional magnetic resonance (MR) imaging. A multifunctional approach with diffusion-weighted imaging, perfusion-weighted imaging, and permeability maps, along with H-MRS, may enhance the accuracy of the diagnosis and characterization of brain tumors and estimation of therapeutic response. Integration of advanced imaging techniques with conventional MR imaging and the clinical history help to improve the accuracy, sensitivity, and specificity in differentiating tumors and nonneoplastic lesions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with space-occupying lesions

排除标准

  • Post operative cases
  • Non-neoplastic nature

结局指标

主要结局

Comparison of MRS findings with the pathology of the specimens

时间窗: Baseline

Analysis of the MRS metabolites peaks and integral and test if they can differentiate the grades of brain tumors

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Abdelwahab

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验